NASDAQ : LFMD
LifeMD, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 2.32 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 111.83M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 110.38M |
| Enterprise Value | 91.26M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 48.20M |
| Shares Outstanding | 48.20M |
| Shares Change (YoY) | +9.50% |
| Shares Change (QoQ) | +0.96% |
| Owned by Insiders (%) | 14.19% |
| Owned by Institutions (%) | 47.90% |
| Float | 39.66M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| Forward PS | 0.49 |
| PB Ratio | 13.75 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.90 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -85.40 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -515.90% |
| Return on Assets (ROA) | -18.92% |
| Return on Invested Capital (ROIC) | -69.33% |
| Return on Capital Employed (ROCE) | -152.06% |
| Weighted Average Cost of Capital (WACC) | 14.57% |
| Revenue Per Employee | $544,297 |
| Profits Per Employee | -$8,254 |
| Employee Count | 352 |
| Asset Turnover | 2.87 |
| Inventory Turnover | 7.72 |
Taxes
| Measure | Value |
|---|
| Income Tax | 45,721 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.99 |
| 52-Week Price Change | -62.58% |
| 50-Day Moving Average | 2.82 |
| 200-Day Moving Average | 3.66 |
| Relative Strength Index (RSI) | 38.77 |
| Average Volume (20 Days) | 676,745 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 7.40M |
| Short Previous Month | 7.56M |
| Short % of Shares Out | 15.35% |
| Short % of Float | 18.65% |
| Short Ratio (days to cover) | 10.23 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 191.59M |
| Gross Profit | 167.64M |
| Operating Income | -20.20M |
| Pretax Income | -21.49M |
| Net Income | -2.91M |
| EBITDA | -18.96M |
| EBIT | -20.20M |
| Loss Per Share | -$0.09 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 25.14M |
| Total Debt | 6.02M |
| Net Cash | 19.12M |
| Net Cash Per Share | $0.40 |
| Equity (Book Value) | 7.97M |
| Book Value Per Share | 0.17 |
| Working Capital | -4.52M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -6.69M |
| Capital Expenditures | -1.15M |
| Depreciation & Amortization | 1.24M |
| Net Borrowing | -16.67M |
| Free Cash Flow | -7.84M |
| FCF Per Share | -$0.16 |
Margins
| Measure | Value |
|---|
| Gross Margin | 87.50% |
| Operating Margin | -10.54% |
| Pretax Margin | -11.22% |
| Profit Margin | 0.10% |
| EBITDA Margin | -9.89% |
| EBIT Margin | -10.54% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -9.50% |
| Shareholder Yield | -9.50% |
| Earnings Yield | -3.78% |
| FCF Yield | -7.10% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $8.13 |
| Price Target Difference | 254.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 13.27% |
| EPS Growth Forecast (3Y) | 56.36% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 14, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.87 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |